Valadan Mehrnaz, Banifatemi Sakineh, Yousefshahi Fardin
Obstetrics and Gynecology Department, Women Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Anesthesiology and Critical Care Department, Women Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Anesth Pain Med. 2015 Dec 5;5(6):e31524. doi: 10.5812/aapm.31524. eCollection 2015 Dec.
Patients undergoing gynecology laparoscopy frequently experience shoulder pain as a common postoperative complication. Considering diaphragm stimulation in its pathophysiology, there are some advice to prevent or control this special form of referral pain.
The current study aimed to assess the prophylactic effect of preoperative administration of oral gabapentin to prevent Post Laparoscopic Shoulder Pain (PLSP) after laparoscopic ovarian cystectomy.
In a randomized, double blind, placebo controlled trial 40 female patients who were candidates to have elective laparoscopic ovarian cystectomy, received uniformed capsules containing gabapentin 600 mg or placebo 30 minutes before anesthesia induction. All patients had the American Society of Anesthesiologists (ASA) Physical Status of I-II and none had pervious abdominal surgery. Thereafter, the presence of side effects and PLSP and its severity was assessed by Visual Analog Scale (VAS) in the beginning of surgery and 2, 6, 12 hours after the surgery.
Comparing the gabapentin (n = 20) and placebo (n = 20) groups, basic characteristics including age (P = 0.446), Body Mass Index (BMI) (P = 0.876), pregnancy history (P = 0.660), and surgery time (P = 0.232) were statistically similar. PLSP occurrence was less frequent in the gabapentin group (45%) compared with the placebo group (75%) (P = 0.053), while In gabapentin group the VAS scores were lower in 2(P = 0.004), 6 (P = 0.132), and 12 (P = 0.036) hours, post operatively.
Prophylactic gabapentin administration could be considered as an effective and safe intervention to reduce occurrence and severity of PLSP after gynecologic laparoscopic cystectomy.
接受妇科腹腔镜手术的患者经常会经历肩部疼痛,这是一种常见的术后并发症。考虑到其病理生理学中的膈肌刺激因素,有一些预防或控制这种特殊形式牵涉痛的建议。
本研究旨在评估术前口服加巴喷丁对预防腹腔镜卵巢囊肿切除术后腹腔镜后肩部疼痛(PLSP)的预防效果。
在一项随机、双盲、安慰剂对照试验中,40名择期行腹腔镜卵巢囊肿切除术的女性患者在麻醉诱导前30分钟服用含600毫克加巴喷丁的统一胶囊或安慰剂。所有患者的美国麻醉医师协会(ASA)身体状况为I-II级,且均未接受过腹部手术。此后,在手术开始时以及术后2、6、12小时,通过视觉模拟评分法(VAS)评估副作用、PLSP及其严重程度。
比较加巴喷丁组(n = 20)和安慰剂组(n = 20),年龄(P = 0.446)、体重指数(BMI)(P = 0.876)、妊娠史(P = 0.660)和手术时间(P = 0.232)等基本特征在统计学上相似。加巴喷丁组PLSP的发生率(45%)低于安慰剂组(75%)(P = 0.053),而加巴喷丁组术后2小时(P = 0.004)、6小时(P = 0.132)和12小时(P = 0.036)的VAS评分较低。
预防性给予加巴喷丁可被视为一种有效且安全的干预措施,以降低妇科腹腔镜囊肿切除术后PLSP的发生率和严重程度。